This article is more than 5 years old. Information may no longer be current.
DePuy Synthes to acquire assets of Medical Enterprises Distribution LLC
Click Here to Manage Email Alerts
DePuy Synthes Products Inc., part of the Johnson & Johnson Medical Devices Companies, announced it has signed a definitive agreement to acquire assets of Medical Enterprises Distribution LLC. The agreement is expected to close in the second quarter of 2018, according to a press release.
The agreement includes acquisition of the ME1000 surgical impactor, a battery-powered device that automates bone preparation, implant assembly and positioning in total hip arthroplasty. The device can be used with various surgical approaches, such as the anterior approach. DePuy Synthes also has an exclusive marketing agreement with JointPoint Inc. to co-market a hip navigation system for analysis of implant selection and positioning during THA. According to the release, JointPoint is compatible with the ME1000.
“The role that automation and digital technology are playing in orthopedics, including joint replacement surgery, is tremendous, and our goal is to be at the forefront of providing surgeons with innovative and differentiated solutions that help increase efficiency as well as generate more predictable and reproducible patient outcomes,” Ciro Rmer, company group chairman of DePuy Synthes, said in the release. “The acquisition of assets of Medical Enterprises Distribution is a key example of going beyond the implant to provide complete solutions to achieve better outcomes.”
Reference: